
Semalytix is a company that leverages artificial intelligence and natural language processing to provide insights into patient and physician experiences for the life sciences and pharmaceutical industries. Their core offering is the Pharos Suite, which analyzes vast amounts of online conversations and patient data to identify unmet needs, treatment experiences, and quality-of-life impacts. Semalytix aims to accelerate research, de-risk clinical trials, and improve patient-centricity by providing data-driven insights. They have a unique blend of expertise in AI, machine learning, medicine, and pharmaceuticals, and have been chosen by top pharma customers. Their solutions help validate commercial potential, improve study design, and complement Real-World Data strategies.

Semalytix is a company that leverages artificial intelligence and natural language processing to provide insights into patient and physician experiences for the life sciences and pharmaceutical industries. Their core offering is the Pharos Suite, which analyzes vast amounts of online conversations and patient data to identify unmet needs, treatment experiences, and quality-of-life impacts. Semalytix aims to accelerate research, de-risk clinical trials, and improve patient-centricity by providing data-driven insights. They have a unique blend of expertise in AI, machine learning, medicine, and pharmaceuticals, and have been chosen by top pharma customers. Their solutions help validate commercial potential, improve study design, and complement Real-World Data strategies.
Founded: 2015
Headquarters: Bielefeld, Nordrhein-Westfalen, Germany
Product: Pharos — AI-based real-world evidence / patient-experience analytics platform
Employees: 38
Known funding: €4.3M Series A (announced 2020); total funding reported ≈ $7.55M
Real-world evidence, patient-experience analytics, semantic analysis of unstructured health data
2015
Life sciences / Health tech / AI
€4.3M
Round reported to expand the Pharos patient-experience data set
Latest funding date recorded in company snapshot data
“NRW.BANK, Matterwave Ventures, Fly Ventures listed among recorded investors; individual investor/advisor names appear on company materials”